scholarly journals Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease

2012 ◽  
Vol 18 (1) ◽  
pp. 25-33 ◽  
Author(s):  
Jennifer C.C. deBruyn ◽  
Robert Hilsden ◽  
Kevin Fonseca ◽  
Margaret L. Russell ◽  
Gilaad G. Kaplan ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Influenza Vaccination ◽  
Bowel Disease ◽  
Inflammatory Bowel

scholarly journals Su1798 – The Influenza Vaccination and Pediatric Inflammatory Bowel Disease

2019 ◽  
Vol 156 (6) ◽  
pp. S-616
Author(s):  
Jamie Mathew ◽  
Sharon Thomas ◽  
Randa Samaha ◽  
Erealda Prendaj ◽  
Gitit Tomer
Keyword(s):  
Inflammatory Bowel Disease ◽  
Influenza Vaccination ◽  
Bowel Disease ◽  
Pediatric Inflammatory Bowel Disease ◽  
Inflammatory Bowel

Sa015 IMPROVING INFLUENZA VACCINATION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A QUALITY IMPROVEMENT INITIATIVE

2021 ◽  
Vol 160 (6) ◽  
pp. S-391
Author(s):  
Sharmistha Rudra ◽  
Andrew B. Grossman ◽  
Maura Downing ◽  
Jillian Hillman ◽  
Kerry A. Ashcroft ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Quality Improvement ◽  
Influenza Vaccination ◽  
Bowel Disease ◽  
Quality Improvement Initiative ◽  
Pediatric Inflammatory Bowel Disease ◽  
Inflammatory Bowel

scholarly journals Influenza vaccination coverage in children with inflammatory bowel disease

2014 ◽  
Vol 8 (4) ◽  
pp. 431-435 ◽  
Author(s):  
Aleksandra Banaszkiewicz ◽  
Beata Klincewicz ◽  
Izabella Łazowska-Przeorek ◽  
Urszula Grzybowska-Chlebowczyk ◽  
Paulina Kąkol ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Influenza Vaccination ◽  
Vaccination Coverage ◽  
Bowel Disease ◽  
Inflammatory Bowel

Mo1353 Immunomodulator and/or Infliximab Inhibit the Immunoresponses for Trivalent Influenza Vaccination in Adult Patients With Inflammatory Bowel Disease

2013 ◽  
Vol 144 (5) ◽  
pp. S-644-S-645
Author(s):  
Yoshie Hagihara ◽  
Kenji Watanabe ◽  
Hirokazu Yamagami ◽  
Takuya Tsukahara ◽  
Kenichi Morimoto ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Influenza Vaccination ◽  
Bowel Disease ◽  
Adult Patients ◽  
Inflammatory Bowel

The efficiency of influenza vaccines in patients with inflammatory bowel disease on immunosuppressive therapy

2012 ◽  
Vol 153 (47) ◽  
pp. 1870-1874 ◽  
Author(s):  
Klaudia Farkas ◽  
Gabriella Terhes ◽  
Judit Deák ◽  
Anita Bálint ◽  
Ferenc Nagy ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Influenza Vaccination ◽  
Immunosuppressive Therapy ◽  
Bowel Disease ◽  
Influenza Viruses ◽  
Vaccine Acceptance ◽  
Local Adverse Effect ◽  
Antibody Titers ◽  
2009 H1n1 ◽  
Inflammatory Bowel

Introduction: Inactivated influenza vaccination is recommended yearly for patients with inflammatory bowel disease on immunosuppressive therapy. Aim: The aim of our study was to evaluate the immune response to seasonal influenza vaccination in patients with inflammatory bowel disease treated with immunosuppressants. Patients and methods: Thirty patients were enrolled in this prospective study. Each patient was diagnosed with inflammatory bowel disease and treated with immunosuppressants. Blood samples were obtained from patients before and one month after influenza vaccination (A/California/7/2009(H1N1), A/Perth/16/2009(H3N2) B/Brisbane/60/2008) to assess the pre-and postimmunization antibody titers. Virus-specific antibodies were measured by ELISA. Results: The vaccine acceptance rate was 53.3%. Local adverse effect occurred in 5 patients. Seven patients developed systemic adverse events. Influenza-like symptoms occurred in 2 patients, although their antibody titers failed to increase significantly. Antibodies to influenza viruses were detected in each patient before the vaccination. Conclusion: The results confirmed that each patient had appropriate antibody titer as correlation of protection even before the immunisation. Seroprotection rates were not influenced by the vaccination. The vaccine seemed to be safe. Orv. Hetil., 2012, 153, 1870–1874.

Sign in / Sign up

Export Citation Format

Share Document